Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Pharmacology and clinical development of GIP/GLP-1/glucagon triple agonists
The physiological evidence for a direct action of GLP-1 on pancreatic acinar cells is unclear
Despite the promise of these new therapies to address all parts of the CVD/diabetes/obesity triad, approval and broad reimbursement for all these uses are likely still a few years off
In this article, well explore how peptides work, their benefits, and how they can be integrated into a well-rounded anti-aging strategy
doi: 10.1094/MPMI-03-22-0063-R 13 Diaz-VivancosP.WolffT.MarkovicJ.PallardF
Protein disulphide isomerase protects against protein aggregation and is S-nitrosylated in amyotrophic lateral sclerosis
US$ 27.91
US$ 20.62
US$ 23.33
US$ 26.66
US$ 24.90
